… PFS is plotted according to PD-L1 expression level with a cutoff of 50% in tumor samples
obtained after EGFR-TKI treatment (D) or according to a change in PD-L1 expression status …

… , inhibitors of EGFR (epidermal growth factor receptor), has a … However, there are cancer
cells resistant to drugs’ treatment … in response to treatment in biopsy-derived cells compared to …

… and status of EGFR inhibitors in cancer therapy. In addition, we … The epidermal growth factor
receptor (EGFR) is a family of … better EGFR inhibition than urea containing derivatives. The …

… the highly effective antibodies targeting epidermal growth factor receptor (EGFR), have clinical
… to EGFR inhibitors. At the same time, the study also pointed out that the resistance to anti-…

… Targeted treatments have been shown to improve survival in … However, the majority of
patients derived benefit from re-… AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer…

… We describe the expanding landscape of anti-FGFR therapies that … , such as epidermal
growth factor receptor (EGFR) and … that FGFR inhibition with AZD4547 and EGFR inhibition with …

… to anti‐epidermal growth factor receptor (EGFR) treatment. … be obtained by a future independent
data set was 0.54. Referring to the subset of patients treated with anti‐EGFR therapy, the …

… Targeting the epidermal growth factor receptor (EGFR) either … (mCRC) has revolutionized
the treatment of CRC, but with … and EGFR inhibitors is able to decrease the in vitro growth of …

… was designed, synthesised and evaluated for antitumor activity in vitro on wild type epidermal
growth factor receptor tyrosine kinase (EGFR wt -TK) and three human cancer cell lines …

… chemotherapy was the only option to treat advanced NSCLC, but showed … epidermal growth
factor receptor (EGFR) overexpression in NSCLC, various EGFR tyrosine kinase inhibitors …